Biotech IT News
> 10 Big Pharma smartphone apps. Slideshow
> 15 mobile apps in Life Sciences - 2012. Slideshow
> Fierce's Top 10 Biotech Techies. Special Report
> FDA dishes out long-awaited guidance on social media. Article
> Roche getting entire workforce to use Google Apps. Story
CRO News
> 'Dateline' exposé snares Indian CROs in an ethics 'sting'. More
> Report: 438 died in Indian clinical trials last year. Article
> Top Emerging CRO Markets. Special Report
> FierceCRO's Top 5 Strategic CRO/Pharma Partnerships. Special Report
> Top CRO executives predict industry's future. Story
Pharma Manufacturing News
> FDA report shows deep problems at closed Novartis Consumer Health plant. Story
> FDA ravages Sanofi vaccine sterility process in warning letter. More
> Fierce's 2012 Top 10 FDA Red Flags. Special Report
> Novartis says Nebraska plant to reopen midyear. Article
> Explosion, fire at Teva's Pliva plant turns deadly. More
Biotech Research News
> Fish oil wipes out leukemia in mice. More
> New compound nearly wipes out HIV in cells. Story
> Top 20 Research Institute Salaries. Special Report
> Meet cancer's latest enemy: grape seed extract. Article
> Fight colon cancer with veggies, plus 2 other discoveries. More
Drug Delivery News
> Fierce's 5 Drug Delivery Companies to Watch. Special Report
> Top 5 Insulin-Delivery Techs To Watch. Special Report
> Ex-Sanofi exec takes helm at Bob Langer startup. Article
> This could be the year of nanotech-enabled medicines. Editor's Corner
> Kala Pharmaceuticals, co-launched by MIT's Langer, snags $6.2M. More
Biomarkers News
> Inflammatory protein marks heart disease. Story
> Biomarkers rescue Amgen's MAb, support Roche's Avastin. More
> Qiagen signs diagnostic biomarker deals. Article
> Biomarker could quickly diagnose heart attack. Story
> Alzheimer's marker is seen in middle age. Item
Vaccines News
> Genocea's HSV-2 vax to hit the clinic. More
> 10 promising therapeutic vaccines 2012. Special Report
> 20 Top-selling Vaccines -- H1 2012. Special Report
> Breast cancer vaccine set for large-scale testing. Article
> MedImmune to cut 200 jobs, layoffs hit vax R&D. Story